HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jon-Kar Zubieta Selected Research

Raclopride

10/2017Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
4/2017Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
7/2015Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.
10/2012Leptin regulates dopamine responses to sustained stress in humans.
8/2012Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner.
2/2008Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
9/2007Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jon-Kar Zubieta Research Topics

Disease

41Pain (Aches)
12/2022 - 06/2002
10Chronic Pain
12/2022 - 09/2009
8Opioid-Related Disorders (Opiate Addiction)
12/2022 - 01/2007
8Substance-Related Disorders (Drug Abuse)
06/2019 - 10/2009
8Major Depressive Disorder (Major Depressive Disorders)
01/2019 - 01/2009
7Migraine Disorders (Migraine)
07/2019 - 06/2014
6Fibromyalgia (Fibrositis)
10/2016 - 09/2007
5Mood Disorders (Mood Disorder)
01/2019 - 07/2012
4Headache (Headaches)
01/2019 - 06/2014
4Hyperalgesia
04/2017 - 06/2014
3Back Pain (Backache)
01/2022 - 09/2013
3Mental Disorders (Mental Disorder)
06/2019 - 01/2014
3Obesity
08/2015 - 07/2009
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
07/2013 - 07/2009
2Alcoholism (Alcohol Abuse)
06/2019 - 08/2014
2Bipolar Disorder (Manic Depressive Psychosis)
06/2019 - 11/2016
2Heroin Dependence (Heroin Abuse)
10/2015 - 11/2003
2Insulin Resistance
06/2011 - 07/2009
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2007 - 11/2003
1Genetic Risk Score
01/2022
1Drug Misuse
01/2020
1Schizophrenia (Dementia Praecox)
06/2019
1Treatment-Resistant Depressive Disorder
01/2019
1Cicatrix (Scar)
10/2017
1Anhedonia
10/2017
1Alcoholic Intoxication (Drunkenness)
03/2017
1Cognitive Dysfunction
01/2017
1Weight Loss (Weight Reduction)
08/2015
1Feeding and Eating Disorders (Eating Disorder)
10/2012
1Neuralgia (Stump Neuralgia)
09/2012
1Alcohol-Related Disorders
08/2012
1Myalgia
08/2012
1Cushing Syndrome
01/2012
1Tobacco Use Disorder (Nicotine Dependence)
05/2011
1Borderline Personality Disorder (Personality Disorders, Borderline)
08/2010
1Personality Disorders (Personality Disorder)
10/2009
1Infertility (Sterility)
07/2009
1Hyperinsulinism (Hyperinsulinemia)
07/2009
1Wounds and Injuries (Trauma)
05/2007
1Psychological Trauma
05/2007
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2007
1Nociceptive Pain
06/2002

Drug/Important Bio-Agent (IBA)

42Opioid Analgesics (Opioids)IBA
12/2022 - 06/2002
18Opioid Receptors (Opioid Receptor)IBA
12/2022 - 06/2002
15Neurotransmitter Agents (Neurotransmitter)IBA
12/2022 - 06/2002
13carfentanil (carfentanyl)IBA
12/2022 - 11/2003
12mu Opioid Receptors (mu Opioid Receptor)IBA
01/2017 - 06/2002
10Analgesics (Analgesic Drugs)IBA
01/2022 - 06/2002
9Dopamine (Intropin)FDA LinkGeneric
10/2017 - 10/2006
7RacloprideIBA
10/2017 - 09/2007
5Pharmaceutical PreparationsIBA
01/2020 - 08/2012
4salicylhydroxamic acid (SHAM)IBA
02/2016 - 09/2009
3Biomarkers (Surrogate Marker)IBA
12/2022 - 03/2015
3Hydrocortisone (Cortisol)FDA LinkGeneric
11/2016 - 01/2012
3Insulin (Novolin)FDA Link
07/2013 - 07/2009
2CytokinesIBA
01/2022 - 02/2015
2Glucose (Dextrose)FDA LinkGeneric
07/2013 - 07/2009
2Narcotic Antagonists (Opioid Antagonists)IBA
07/2009 - 06/2007
2Hydromorphone (Dilaudid)FDA LinkGeneric
01/2007 - 11/2003
2Heroin (Diamorphine)IBA
01/2007 - 11/2003
2CatecholaminesIBA
08/2005 - 02/2003
2Opiate AlkaloidsIBA
08/2005 - 06/2002
1Interleukin-18 (Interleukin 18)IBA
01/2022
1A-factor (Streptomyces)IBA
01/2022
1N-acetylcysteine lysinateIBA
01/2020
1Therapeutic UsesIBA
10/2019
1Oxytocin (Pitocin)FDA LinkGeneric
12/2016
1Interleukin-1 (Interleukin 1)IBA
02/2015
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2014
1valylvaline (Val-Val)IBA
04/2014
1LeptinIBA
10/2012
1Illicit Drugs (Recreational Drugs)IBA
08/2012
1SmokeIBA
08/2012
15-HT2C Serotonin ReceptorIBA
07/2012
1NucleotidesIBA
07/2012
1Corticotropin-Releasing HormoneIBA
02/2012
1Biological ProductsIBA
01/2009
1CarbonIBA
02/2008
1Carbon DioxideIBA
01/2007
1Buprenorphine (Subutex)FDA LinkGeneric
01/2007
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2006
1Estrogens (Estrogen)FDA Link
05/2006
1Amphetamine (Amfetamine)FDA LinkGeneric
04/2004
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
02/2003

Therapy/Procedure

7Analgesia
01/2022 - 01/2006
4Transcranial Direct Current Stimulation
02/2016 - 01/2012
3Therapeutics
02/2015 - 08/2005
2Drug Therapy (Chemotherapy)
01/2018 - 12/2016
1Patient Readmission
06/2019
1Secondary Prevention
10/2017
1Caloric Restriction
08/2015
1Precision Medicine
02/2013
1Acupuncture Therapy
09/2009